refractory or relapsed aml
Item
patients with refractory or relapsed aml ( marrow blasts > 20% ), must have failed induction therapy or have relapsed after cr duration < 6 months following induction therapy, untreated or refractory to salvage chemotherapy. relapsed aml patients with cr duration > 6 months or previously untreated patients refusing chemotherapy and not considered for treatments of higher priority are also eligible.
boolean
C0023467 (UMLS CUI [1])
chronic myelomonocytic leukemia
Item
patients with chronic myelomonocytic leukemia (cmml) who failed at least one course of chemo- or biological therapy( including trial of erythropoietin), or patients with relapsed cmml. previously untreated cmml patients with hb < or = 12 g / dl, not eligible for protocols of higher priority or not wishing to receive chemotherapy.
boolean
C0023480 (UMLS CUI [1])
ecog performance status
Item
patients must have an ecog performance status of < 2.
boolean
C1520224 (UMLS CUI [1])
wbc count
Item
patients must have wbc count < 10,000/ml prior to initiating the treatment. the wbc count must be stabilized below this level for at least three days by leukopheresis or hydroxyurea. hydroxyurea must be discontinued one day prior to initiation of dt388gmcsf treatment.
boolean
C0023508 (UMLS CUI [1])
organ parameters
Item
patients must have creatinine < 1.6 times uln: bilirubin <1.6 times uln; sgpt < 2.6 x uln; albumin > 3 gm/dl; adequate cardiac function (ef >44%), oxygen saturation > 92% without exogenous oxygen administered.
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201838 (UMLS CUI [4])
C0232174 (UMLS CUI [5])
C0523807 (UMLS CUI [6])
patients must be willing to be treated at m d anderson cancer center.
Item
patients must be willing to be treated at m d anderson cancer center.
boolean
contraception
Item
women of childbearing potential and men must agree to practice contraception using approved methods.
boolean
C0700589 (UMLS CUI [1])
chemotherapy
Item
no chemotherapy except hydroxyurea 2 weeks prior to entering the study and recovered from previous toxicity.
boolean
C0392920 (UMLS CUI [1])
age
Item
patients must be > 17 years old.
boolean
C0001779 (UMLS CUI [1])
infections
Item
patients with serious concurrent medical problems. patients with proven bacterial infections are not eligible until the resolution of the infection (patient afebrile who completed antibacterial therapy, not on steroids). patients with active fungal infections are eligible only if evidence of response to antifungal medications is documented and fever does not exceed 38c for at least 2 days.
boolean
C0009450 (UMLS CUI [1])
inability to give informed consent
Item
inability to give informed consent because of psychiatric problems or other serious medical problems.
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
pregnancy or lactation
Item
pregnant or nursing women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
cns leukemia
Item
patients with documented cns leukemia or leukemia with cns symptoms.
boolean
C1332884 (UMLS CUI [1])
myocardial infarction
Item
patients who have had a myocardial infarction within the past six months.
boolean
C0027051 (UMLS CUI [1])
penicillin allergy
Item
patients with severe penicillin allergy (anaphylaxis).
boolean
C0020517 (UMLS CUI [1,1])
C0030840 (UMLS CUI [1,2])
toxic effects of chemotherapy or radiation
Item
not fully recovered from toxic effects of prior chemotherapy or radiation therapy.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
corticosteroids
Item
patients who are on corticosteroid treatment for any medical condition.
boolean
C0001617 (UMLS CUI [1])